Abstract
Linear IgA bullous dermatosis (LABD) is a rare immunobullous condition known to affect the skin and mucous membranes of the eye and oral cavity in adults and young children. We describe a newborn with skin involvement who had life-threatening respiratory compromise from disease affecting the larynx, subglottis, trachea, and esophagus. Management with both tracheostomy and gastrostomy tube placement was necessary. Treatment included systemic steroids, dapsone, and intravenous immunoglobulin. We compare our neonatal case to the only other report in the literature highlighting involvement of the mucous membranes of multiple levels of the aerodigestive tract leading to respiratory compromise.
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Catheterization
-
Combined Modality Therapy
-
Dapsone / therapeutic use
-
Dexamethasone / therapeutic use
-
Esophageal Diseases / etiology*
-
Esophageal Diseases / pathology
-
Esophageal Diseases / therapy
-
Esophagoscopy / methods
-
Humans
-
Immunoglobulin A / immunology*
-
Immunoglobulins, Intravenous / therapeutic use
-
Infant, Newborn
-
Laryngeal Diseases / etiology*
-
Laryngeal Diseases / pathology
-
Laryngeal Diseases / therapy
-
Male
-
Mucous Membrane / pathology
-
Respiratory Insufficiency / etiology
-
Respiratory Insufficiency / surgery
-
Skin Diseases, Vesiculobullous / complications*
-
Skin Diseases, Vesiculobullous / immunology*
-
Tracheal Diseases / etiology*
-
Tracheal Diseases / pathology
-
Tracheal Diseases / therapy
Substances
-
Anti-Inflammatory Agents
-
Immunoglobulin A
-
Immunoglobulins, Intravenous
-
Dexamethasone
-
Dapsone